Published Paper Details:

Introduction: Schizophrenia is a chronic psychiatric disorder with a heterogeneous genetic and neurobiological background that influences early brain development, and is expressed as a combination of psychotic symptoms -- such as hallucinations, delusions and disorganization -- and motivational and cognitive dysfunctions. Aim: To discuss a case of 23 years old male with history of 2 episodes of seizures due to neurocysticercosis presented with symptoms of schizophrenia. Results: Patient showed significant improvement with treatment (started interacting, suspiciousness reduced, catatonic symptoms improved) following which he was discharged from the hospital. Conclusion: Treatment Resistant Schizophrenia (TRS) represents a major clinical challenge. Clozapine is recognized as most effective treatment option worldwide. Earlier and broader use of clozapine in patients with TRS is an important measure to improve outcomes of patients with this most severe form of the illness.